Search Icon
ERAS Archived Articles

Erasca: Prioritizing RAS Targeting with Extended Runway (ERAS)

Published on June 18, 2025

Erasca: Navigating the Uncharted Frontiers of Precision Oncology

Published on March 15, 2025

Erasca (ERAS): Pioneering the Fight Against RAS/MAPK-Driven Cancers

Published on November 05, 2024

Erasca, Inc. (NASDAQ:ERAS): Unlocking the Potential of RAS/MAPK Pathway Inhibition

Published on September 24, 2024